• IL Therapeutics Inc. was previously owned by Western Life Sciences Venture Fund LP ("Western Life Sciences") and in 2006 its shares were purchased by...
    5 KB (342 words) - 15:34, 14 October 2021
  • Thumbnail for List of companies of Canada
    Financial Financials Asset managers Winnipeg 1926 Asset management P A IL Therapeutics Health care Biotechnology Saskatoon 2005 Bio-tech P A IMAX Corporation...
    86 KB (695 words) - 02:54, 5 November 2024
  • Plasma Resources Guardian Biotechnologies Great Western Brewing Company IL Therapeutics Prairie Plant Systems Robin Hood Flour Affinity Credit Union First...
    3 KB (195 words) - 17:09, 22 August 2024
  • Thumbnail for Roche
    operations. In September 2022, Roche acquired Good Therapeutics at a cost of $250M for its PD1-regulated IL-2 receptor agonist program. In July 2023, Roche...
    57 KB (5,195 words) - 10:21, 4 November 2024
  • org. Retrieved 2021-06-22. Therapeutics, Neoleukin (June 2020). "NL-201: A de novo CD25-independent combined IL-2 and IL-15 receptor agonistdesigned...
    4 KB (388 words) - 23:01, 13 December 2023
  • Thumbnail for AbbVie
    Topokine Therapeutics (Acq 2016) Vitae Pharmaceuticals, Inc (Acq 2016) Tobira Therapeutics (Acq 2016) ForSight VISION5 (Acq 2016) RetroSense Therapeutics (Acq...
    42 KB (3,542 words) - 10:02, 1 November 2024
  • Thumbnail for Sotio
    Swiss NBE-Therapeutics on the development of novel antibody-drug conjugate products (ADC), with its affiliate Cytune Pharma on developing novel IL-15-based...
    12 KB (1,170 words) - 14:35, 24 August 2024
  • bio-technology companies, these include Guardian Biotechnologies, IL Therapeutics among others. Most major Canadian banks and financial services companies...
    27 KB (2,951 words) - 04:42, 8 September 2024
  • Anti-interleukin-6 agents are a class of therapeutics. Interleukin 6 is a cytokine relevant to many inflammatory diseases and many cancers. Hence, anti-IL6...
    12 KB (1,289 words) - 19:20, 4 December 2023
  • proliferate CD8+ T cells and NK cells. It is being developed by Nektar Therapeutics. In August 2019 the FDA granted breakthrough therapy designation to bempegaldesleukin...
    7 KB (599 words) - 00:43, 16 August 2023